Company profile: Redsense
1.1 - Company Overview
Company description
- Provider of a hemodialysis blood leak monitoring system using patented fiber optic technology, including the Redsense Alarm System, a disposable sensor patch, and an extension fiber to detect blood contact and alert for needle dislodgement or leakage; offers an automatic off-switch feature for compliant dialysis machines and training and education services.
Products and services
- Automatic Off-Switch Feature: IEC PAS63023-compliant capability that closes the venous clamp automatically when blood is detected, integrating with compatible dialysis machines to immediately stop blood flow
- Redsense Alarm System: Medical-grade monitoring unit for hemodialysis that detects blood contact at the access site via sensor patch, triggering immediate visual and audible alarms for needle dislodgement or leakage
- Sensor Patch: Fiber-optic, non-invasive disposable patch placed over the blood access site during dialysis, detecting the first sign of blood to trigger Redsense’s audible and visual alarms
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Redsense
Quanta Dialysis Technologies
HQ: United Kingdom
Website
- Description: Provider of advanced haemodialysis systems for use in the home and clinic, focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based, high-performance, compact haemodialysis system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quanta Dialysis Technologies company profile →
Iviva Medical
HQ: United States
Website
- Description: Provider of bioartificial kidney solutions for end-stage kidney disease, including fully implantable bioartificial kidneys; proprietary 3D-printed scaffold construction for human-scale solute-exchange grafts; Thin Film Interposition scaffolding; biologic blood purification with a cellular membrane-based device; and autologous renal grafts from patient-derived cells potentially eliminating the need for immunosuppression.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Iviva Medical company profile →
Diality
HQ: United States
Website
- Description: Provider of the Moda-flx Hemodialysis System, a portable hemodialysis machine for home use that enables patients with kidney disease to self-treat; a medical device company developing solutions that improve lives impacted by kidney disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diality company profile →
CreatiVasc
HQ: United States
Website
- Description: Provider of innovative, easy-to-use vascular technologies and medical devices for the treatment of end-stage renal disease, addressing universal problems of vascular access for dialysis patients to improve survivability and quality of life; founded in 2004.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CreatiVasc company profile →
Hemotune
HQ: Switzerland
Website
- Description: Provider of a therapeutic blood purification platform and products: HemoSystem using magnetic beads to selectively remove large biomolecules for conditions like sepsis; HemoBeads with ultra-magnetic cores and affinity binders; HemoDevice, a reusable extracorporeal device; HemoDisposable sterile single-use tubing; and reSEPT Therapy to restore immune balance in septic shock.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemotune company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Redsense
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Redsense
2.2 - Growth funds investing in similar companies to Redsense
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Redsense
4.2 - Public trading comparable groups for Redsense
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →